JPMorgan Downgrades BioNTech (BNTX) to Underweight, 'Waiting for a More Catalyst-Rich Period'
Tweet Send to a Friend
(Updated - December 1, 2023 4:23 AM EST)
JPMorgan analyst Jessica Fye downgraded BioNTech (NASDAQ: BNTX) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Jessica Fye downgraded BioNTech (NASDAQ: BNTX) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
